PARK7 and Parkinson disease: ICAM-1 mediates cellular inflammation and is potentially modulated by DJ-1 and α-synuclein (2 proteins closely linked to Parkinson’s disease), particularly during neurodegenerative processes that extend beyond the regulatory impact on endothelial functions [34].